Newsroom

Industry News

5 Aug

Luisa Ingargiola Joins CBD Energy (CBDE) Board of Directors

CBD Energy Limited (CBDE) today announced that Luisa Ingargiola has joined the Board as an independent Non-Executive Director, replacing Todd Barlow. Contemporaneous with her appointment to CBDE’s Board, Ms. Ingargiola has been appointed to the Company’s Audit and Compensation Committees. CBD Energy Limited is a diversified clean energy company...

Read more

5 Aug

Boston Therapeutics (BTHE) Expands Medical Advisory Board

Noted Diabetes Experts Meng H Tan, M.D., Philip Raskin, M.D., and Charles M. Clark, Jr., M.D. to Serve as Medical Advisory Board Members Boston Therapeutics, Inc. (OTCQB: BTHE) (“Boston Therapeutics” or “the Company”), a developer of complex carbohydrate therapeutics to treat diabetes, has expanded its Medical Advisory Board with the...

Read more

5 Aug

Actinium (ATNM) to Present at the Canaccord Genuity 34th Annual Growth Conference on August 13th

CEO to Provide Corporate Update on Late- and Mid-Stage Programs Focused on Acute Myeloid Leukemia and Other Advanced Cancers Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Dr. Kaushik J....

Read more

5 Aug

Aeterna Zentaris (AEZS) and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market

Aeterna Zentaris Inc. (AEZS) (TSX: AEZ) (the “Company”) today announced a strategic co-promotion services agreement with ASCEND Therapeutics® US, LLC, (“ASCEND”). Under the terms of the agreement, expected to start in the fourth quarter of 2014, Aeterna Zentaris will use its newly established commercial structure to market, in specific U.S. territories, ASCEND’s...

Read more

23 Jul

Inovio Pharmaceuticals (INO) HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced successful results from its randomized, double-blind, placebo-controlled phase II trial of VGX-3100 in women with biopsy-proven cervical intraepithelial neoplasia 2/3 (CIN2/3) associated with human papillomavirus (HPV) types 16 or 18. Treatment with VGX-3100, Inovio’s HPV16/18-specific immunotherapy, resulted in histopathological regression of...

Read more

22 Jul

NXT-ID’s (NXTD) Next Generation Wocket Smart Wallet to be Featured on NewsWatch, Airing on History Channel, FYI Network and ION Network

NXT-ID, Inc., (NXTD:OTCQB) a biometric authentication company focused on the growing m-commerce market, announces its next generation smart wallet, Wocket™, will be featured on NewsWatch, a weekly 30-minute consumer oriented television show that airs on the History Channel, FYI Network, and ION Network. NewsWatch regularly features top technology products...

Read more

Page 234 of 244« First...102030...232233234235236...240...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address